Share-based Payment Arrangement, Expense of Jazz Pharmaceuticals plc from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Jazz Pharmaceuticals plc quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Jazz Pharmaceuticals plc Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $88,125,000, a 47% increase year-over-year.
  • Jazz Pharmaceuticals plc Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $290,469,000, a 26% increase year-over-year.
  • Jazz Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2024 was $248,045,000, a 9.3% increase from 2023.
  • Jazz Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2023 was $226,841,000, a 2.2% increase from 2022.
  • Jazz Pharmaceuticals plc annual Share-based Payment Arrangement, Expense for 2022 was $221,996,000, a 17% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Jazz Pharmaceuticals plc Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $290,469,000 $88,125,000 +$28,365,000 +47% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $262,104,000 $64,501,000 +$7,847,000 +14% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $254,257,000 $67,653,000 +$6,212,000 +10% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $248,045,000 $70,190,000 +$17,249,000 +33% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2025 2024 FY
Q3 2024 $230,796,000 $59,760,000 +$3,645,000 +6.5% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $227,151,000 $56,654,000 -$4,779,000 -7.8% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $231,930,000 $61,441,000 +$5,089,000 +9% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $226,841,000 $52,941,000 -$8,617,000 -14% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q3 2023 $235,458,000 $56,115,000 -$566,000 -1% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $236,024,000 $61,433,000 +$7,746,000 +14% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 $228,278,000 $56,352,000 +$6,282,000 +13% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 $221,996,000 $61,558,000 +$8,439,000 +16% 01 Oct 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
Q3 2022 $213,557,000 $56,681,000 +$3,442,000 +6.5% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $210,115,000 $53,687,000 +$5,524,000 +11% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $204,591,000 $50,070,000 +$15,585,000 +45% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $189,006,000 $53,119,000 +$21,735,000 +69% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q3 2021 $167,271,000 $53,239,000 +$22,883,000 +75% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $144,388,000 $48,163,000 +$17,559,000 +57% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $126,829,000 $34,485,000 +$5,831,000 +20% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $120,998,000 $31,384,000 +$5,447,000 +21% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 $115,551,000 $30,356,000 +$1,571,000 +5.5% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $113,980,000 $30,604,000 +$2,315,000 +8.2% 01 Apr 2020 30 Jun 2020 10-Q 03 Aug 2021 2021 Q2
Q1 2020 $111,665,000 $28,654,000 +$1,102,000 +4% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q4 2019 $110,563,000 $25,937,000 -$786,000 -2.9% 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q3 2019 $111,349,000 $28,785,000 +$3,682,000 +15% 01 Jul 2019 30 Sep 2019 10-Q 02 Nov 2020 2020 Q3
Q2 2019 $107,667,000 $28,289,000 +$1,977,000 +7.5% 01 Apr 2019 30 Jun 2019 10-Q 04 Aug 2020 2020 Q2
Q1 2019 $105,690,000 $27,552,000 +$3,249,000 +13% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
Q4 2018 $102,441,000 $26,723,000 -$598,000 -2.2% 01 Oct 2018 31 Dec 2018 10-K 23 Feb 2021 2020 FY
Q3 2018 $103,039,000 $25,103,000 -$2,023,000 -7.5% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019 2019 Q3
Q2 2018 $105,062,000 $26,312,000 -$948,000 -3.5% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $106,010,000 $24,303,000 -$890,000 -3.5% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q4 2017 $106,900,000 $27,321,000 +$3,040,000 +13% 01 Oct 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
Q3 2017 $103,860,000 $27,126,000 +$2,252,000 +9.1% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018 2018 Q3
Q2 2017 $101,608,000 $27,260,000 +$1,827,000 +7.2% 01 Apr 2017 30 Jun 2017 10-Q 07 Aug 2018 2018 Q2
Q1 2017 $99,781,000 $25,193,000 +$1,010,000 +4.2% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q4 2016 $98,771,000 $24,281,000 -$36,000 -0.15% 01 Oct 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
Q3 2016 $98,807,000 $24,874,000 +$1,760,000 +7.6% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $97,047,000 $25,433,000 +$2,133,000 +9.2% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $94,914,000 $24,183,000 +$3,364,000 +16% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q4 2015 $91,550,000 $24,317,000 +$5,297,000 +28% 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
Q3 2015 $86,253,000 $23,114,000 +$4,863,000 +27% 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016 2016 Q3
Q2 2015 $81,390,000 $23,300,000 +$4,748,000 +26% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q1 2015 $76,642,000 $20,819,000 +$7,004,000 +51% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q4 2014 $69,638,000 $19,020,000 +$6,608,000 +53% 01 Oct 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
Q3 2014 $63,030,000 $18,251,000 +$6,375,000 +54% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2015 Q3
Q2 2014 $56,655,000 $18,552,000 +$7,046,000 +61% 01 Apr 2014 30 Jun 2014 10-Q 05 Aug 2015 2015 Q2
Q1 2014 $49,609,000 $13,815,000 +$5,058,000 +58% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015 2015 Q1
Q4 2013 $44,551,000 $12,412,000 +$4,300,000 +53% 01 Oct 2013 31 Dec 2013 10-K 23 Feb 2016 2015 FY
Q3 2013 $40,251,000 $11,876,000 +$5,521,000 +87% 01 Jul 2013 30 Sep 2013 10-Q 04 Nov 2014 2014 Q3
Q2 2013 $34,730,000 $11,506,000 +$6,248,000 +119% 01 Apr 2013 30 Jun 2013 10-Q 05 Aug 2014 2014 Q2
Q1 2013 $28,482,000 $8,757,000 +$5,476,000 +167% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014 2014 Q1
Q4 2012 $23,006,000 $8,112,000 -$2,834,000 -26% 01 Oct 2012 31 Dec 2012 10-K 24 Feb 2015 2014 FY
Q3 2012 $25,840,000 $6,355,000 +$3,160,000 +99% 01 Jul 2012 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 $22,680,000 $5,258,000 +$1,843,000 +54% 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2012 2012 Q2
Q1 2012 $20,837,000 $3,281,000 +$133,000 +4.2% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2012 2012 Q1
Q4 2011 $20,704,000 $10,946,000 01 Oct 2011 31 Dec 2011 10-K 25 Feb 2014 2013 FY
Q3 2011 $3,195,000 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012 2012 Q3
Q2 2011 $3,415,000 01 Apr 2011 30 Jun 2011 10-Q 07 Aug 2012 2012 Q2
Q1 2011 $3,148,000 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012 2012 Q1

Jazz Pharmaceuticals plc Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $248,045,000 +$21,204,000 +9.3% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2025 2024 FY
2023 $226,841,000 +$4,845,000 +2.2% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2025 2024 FY
2022 $221,996,000 +$32,990,000 +17% 01 Jan 2022 31 Dec 2022 10-K 26 Feb 2025 2024 FY
2021 $189,006,000 +$68,008,000 +56% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $120,998,000 +$10,435,000 +9.4% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $110,563,000 +$8,122,000 +7.9% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 $102,441,000 -$4,459,000 -4.2% 01 Jan 2018 31 Dec 2018 10-K 23 Feb 2021 2020 FY
2017 $106,900,000 +$8,129,000 +8.2% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $98,771,000 +$7,221,000 +7.9% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $91,550,000 +$21,912,000 +31% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $69,638,000 +$25,087,000 +56% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $44,551,000 +$21,545,000 +94% 01 Jan 2013 31 Dec 2013 10-K 23 Feb 2016 2015 FY
2012 $23,006,000 +$2,302,000 +11% 01 Jan 2012 31 Dec 2012 10-K 24 Feb 2015 2014 FY
2011 $20,704,000 +$12,485,000 +152% 01 Jan 2011 31 Dec 2011 10-K 25 Feb 2014 2013 FY
2010 $8,219,000 01 Jan 2010 31 Dec 2010 10-K 26 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.